Should we prescribe carbapenem for treating febrile urinary tract infection caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in children with vesicoureteral reflux?

Recent studies are focused on the noninferiority of noncarbapenem therapy for the treatment of extended-spectrum β-lactamases producing Enterobacteriaceae infections to reduce the utilization of carbapenem.

Saved in:
Bibliographic Details
Published inClinical and experimental pediatrics Vol. 64; no. 6; pp. 284 - 285
Main Author Park, Ji Young
Format Journal Article
LanguageEnglish
Published Sŏul Clinical and Experimental Pediatics / Korean Pediatric Society 01.06.2021
Korean Pediatric Society
The Korean Pediatric Society
대한소아청소년과학회
Subjects
Antimicrobial agents
Bacteria
Bacterial infections
Drug resistance
Pediatrics
Urinary tract diseases
Urinary tract infections
Urogenital system
소아과학
Online AccessGet full text

Cover

More Information
Summary:Recent studies are focused on the noninferiority of noncarbapenem therapy for the treatment of extended-spectrum β-lactamases producing Enterobacteriaceae infections to reduce the utilization of carbapenem.
Bibliography:SourceType-Scholarly Journals-1
content type line 14
ObjectType-Editorial-2
ObjectType-Commentary-1
content type line 23
ISSN:2713-4148
2713-4148
DOI:10.3345/cep.2020.01830